Gabelli & Co Investment Advisers’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-114,722	Closed	-$1.67M	–	330
2023 Q1	$1.67M	Buy	+114,722	New	+$1.62M	0.32%	58

Gabelli & Co Investment Advisers's AMYT Position: Q2 2023 in Review

Gabelli & Co Investment Advisers sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 114,722 shares — an estimated $1.67M sold.

Gabelli & Co Investment Advisers first reported a position in AMYT in Q1 2023 and held it in 1 quarter. The position peaked at $1.67M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

Gabelli & Co Investment Advisers reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 114,722 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $1.67M.
Gabelli & Co Investment Advisers first reported a position in Amryt Pharma plc American Depositary Shares in Q1 2023 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Amryt Pharma plc American Depositary Shares position peaked at $1.67M in Q1 2023.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2023, filed 10 Aug 2023.